scispace - formally typeset
W

Wolfram H. Gerlich

Researcher at University of Giessen

Publications -  159
Citations -  8830

Wolfram H. Gerlich is an academic researcher from University of Giessen. The author has contributed to research in topics: Hepatitis B virus & HBsAg. The author has an hindex of 43, co-authored 155 publications receiving 8300 citations.

Papers
More filters
Journal ArticleDOI

Large surface proteins of hepatitis B virus containing the pre-s sequence.

TL;DR: Immunological cross-reactions showed that P39/GP42 is partially homologous to P24/GP27 and GP33/GP36, and a model is presented of how the open reading frame for the viral envelope leads to defined amounts of three different proteins.
Journal ArticleDOI

Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.

TL;DR: Despite recent advances in the management of hepatitis and HIV coinfection, there is no clear consensus among hepatology, infectious diseases and virology experts on treatment of co-infections and patient management.
Journal ArticleDOI

Nucleic Acid Testing to Detect HBV Infection in Blood Donors

TL;DR: Triplex nucleic acid testing detected potentially infectious HBV, along with HIV and HCV, during the window period before seroconversion, and HBV vaccination appeared to be protective, with a breakthrough subclinical infection occurring with non-A2 HBV subgenotypes and causing clinically inconsequential outcomes.
Journal ArticleDOI

Medical Virology of Hepatitis B: how it began and where we are now

TL;DR: The cloning and sequencing of the HBV genome in 1978 paved the way to understand the viral life cycle, and allowed development of efficient vaccines and drugs, and today’s hepatitis B vaccine was the first vaccine produced by gene technology.